chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Vaccine administered after more than 1 temperature excursion; Vaccine administered after more than 1 temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 019B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Mar-2021 at 9:12 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 27-Mar-2021 at 9:12 AM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The age of patient was provided as 70.13.  Concomitant products were not provided.  On 31-Mar-2021, Excursion time was 09 AM, temperature was 29, total doses given for the day was 195, condition of vaccine prior to administration was not frozen, vaccine was moved to fridge on 23-Mar-2021, vial was moved to clinic on 27-Mar-2021. 20 vials were sent to clinic. Vaccine BUD date was 22-Apr-2021.  On 31-Mar-2021, Excursion time was 10 AM, temperature was 3~5, condition of vaccine prior to administration was not frozen, vaccine was moved to fridge on 23-Mar-2021, vial was moved to clinic on 27-Mar-2021. 20 vials were sent to clinic. Vaccine BUD date was 22-Apr-2021.  The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic.  Temperature recordings were taken using a Fisher brand traceable temperature monitor at every hour. After administration, the vial was returned to the freezer/refrigerator, or maintained at room temperature. It was reported that the patient was administered with vaccines that experienced more than 1 temperature excursion during 33 weeks in 2021. The HCP explained that each time a vial was put into a cooler, there was a period of 1 hour or 1 and half hour approximately, when the temperature data logger registered 34 or 35 degree F.  Treatment medications were not reported.
Immediately felt like I couldn?t think normally... weird brain fog, sudden urge to sleep. Figured it was no big deal but over the next day it got worse, fever and chills, then severe headache, stiff neck,  swollen lymph nodes, cognitive impairment... it made me feel like I was never going to get my ability to think normally back. The stiff neck kept getting worse until I could hardly turn my head, brain fog and swollen lymph nodes were severe and lasted three weeks.  It was severe enough that I knew it would be a bad idea to get the second dose. Finally I got better.  I know of no one who had such an extended period of feeling quite ill.  When I first had lyme disease I had an encephalitis. These symptoms were quite similar despite the fact that my Lyme disease is well controlled with medication.
Itchy rash at site of KINRIX injection. Onset 1 day after injection.
I started a couple week after the vaccination with sneezing, eye irritation, skin scratching all over body but mainly on my face and sometimes I would be wheezing at night when I would try to sleep. I also felt had chills and low temp grade fever.
Hard of hearing; Pain in arm/ Sore arm; Headache; This spontaneous case was reported by a consumer and describes the occurrence of HYPOACUSIS (Hard of hearing), PAIN IN EXTREMITY (Pain in arm/ Sore arm) and HEADACHE (Headache) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) injection for Panuveitis.    Concurrent medical conditions included Panuveitis.   On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In 2022, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) Citrate free. In 2021, the patient experienced PAIN IN EXTREMITY (Pain in arm/ Sore arm) and HEADACHE (Headache). On an unknown date, the patient experienced HYPOACUSIS (Hard of hearing). At the time of the report, HYPOACUSIS (Hard of hearing), PAIN IN EXTREMITY (Pain in arm/ Sore arm) and HEADACHE (Headache) outcome was unknown.            Concomitant products were not provided. Treatment medication was not reported.  It was unknown if patient was enrolled in a COVID-19 Vaccine Trial.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
I have arthritis and I take the shot; it seems to be getting louder; This is a spontaneous report from a non-contactable consumer or other non hcp.  A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EL3247, Expiration date: unknown), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as SINGLE DOSE for covid-19 immunisation. Medical history included arthritis.The patient's concomitant medications were not reported. The patient experienced i have arthritis and i take the shot; it seems to be getting louder (arthritis) on an unspecified date with outcome of unknown.    No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Patient experenced  chest pain,non-cardiac. Onsite EMS was called vitals BP 134/86 100% O2 HR 77.  Patient treated, transported to the hospital.
fever 1 hr p/shots 101 vomited 11Pm x 3, Friday x 2; diarrhea Sat then rash on Sun; on forehead, arm, shoulder, back, stomach, seen by MD; rashing fainting 28JUN93;
Immediately after the shot I experienced a tightness and pressure in my left arm with a line going up to my left neck and left cheek and then some numbness in my left cheek that lasted several hours and went away. The next two days I had mild symptoms (e.g., headache, nausea fatigue, bodyaches, chills). My arm pain at the injection sight last three days. Sometimes I feel tingling on my nose similar to when I?ve been wearing an N95 mask for prolonged period but no facial numbness after  the first day
first COVID19 vaccine was given on 12/30/20 and second was given 01/20/2021 which was actually six days early and should not have been given until 1/27/2021
Patient was given Pfizer Bivalent as initial dose in primary series, instead of Monovalent. No adverse event noted after vaccine administered. Vaccine given by staff at event. supervisor was notified regarding error. Pt to receive  Monovalent vaccine as second dose in primary series in 3-8 weeks. Attempted to call pt. X 3, left message.
Blisters in mouth first, then on arms, chest and legs.  Itchy red blisters-This is usually a symptoms on my Lupus
The following day after 2nd dose, no fever but inability to get warm, major fatigue, and every week since 2nd dose chronic fatigue, constant need to take Advil to cope with joint pain and now 6 weeks post 2nd vaccine low grade fevers (99.6F) severe joint paint, and diarrhea.
LEG CRAMPS,WORSEN AND GOT UP TO HER GROIN; MUSCLE ACHES; KNEE AND JOINT PAIN; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE SPASMS (LEG CRAMPS,WORSEN AND GOT UP TO HER GROIN), MYALGIA (MUSCLE ACHES) and ARTHRALGIA (KNEE AND JOINT PAIN) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Knee replacement (Bilateral knee replacement surgery.).    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced MUSCLE SPASMS (LEG CRAMPS,WORSEN AND GOT UP TO HER GROIN), MYALGIA (MUSCLE ACHES) and ARTHRALGIA (KNEE AND JOINT PAIN). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) on 12-Feb-2021 at a dose of 1 dosage form. At the time of the report, MUSCLE SPASMS (LEG CRAMPS,WORSEN AND GOT UP TO HER GROIN), MYALGIA (MUSCLE ACHES) and ARTHRALGIA (KNEE AND JOINT PAIN) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. Treatment medications includes topical analgesics, ice. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Patient developed an extremely sore arm the day of the vaccination, the soreness impacted her ability to sleep for 2-3 nights. Within 24 hours of vaccination, she developed a headache that lasted approximately 1 week. Within 36 hours of vaccination, she developed an itchy rash that covered her trunk (abdomen and chest). Upon assessment of her injection site one  week after vaccination, it was extremely red with very defined borders of erythema.
Received Moderna instead of Pfizer. 0 recommended for younger than age 18.
Got shingles after my 1st shot, horrible enough; This case was reported by a consumer via interactive digital media and described the occurrence of shingles in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 02-JUN-2022 Reporter's Comments:  The patient self-reported this case via interactive digital media. The patient experienced Shingles after receiving 1st dose of Shingles vaccine. The patient said he/ she was so glad and could not imagine how horrible it could have been. The patient said it was horrible enough to go through already being vaccinated. The reporter advised people not to put themselves at risk get their shots. The follow-up would not possible as no contact details were available.
Had fever, chills, vomiting, diarrhea fatigue starting 12/22 fever stop 12/23 other symptoms stayed until 12/26. 12/27 started with fever again symptoms came back and was tested12/28 and 12/29, 12/29 was negative 12/28 was positive 1/12 pneumonia
01/17/2022 I began to feel sick and had a sore throat, headache and coughing, as well as congestion. I thought I had a sinus infection since I didn't have a fever or fatigue. Positive covid test came out on the 19th. I was given a prescription for cough medicine. Recently I was having difficulty breathing a few weeks after contracting covid-19. I went to the ER and they determined there was no clotting. I am now experiencing no symptoms and am feeling better.
Symptoms: Headache, sedation, myalgia and nausea vomiting. Treatment: Ibuprofen.
Patient noticed on the night of the day she received the above mentioned two vaccines that her hands and feet were swollen, itchy, blotchy and painful.
headache; extreme fatigue; joint pain; This is a spontaneous report from a non-contactable consumer. This consumer reported for a female patient. An unspecified age female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number and expiration date: unknown), dose 1 via an unspecified route of administration in the right arm on 01Mar2021 as 1st dose, single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. On 01-MAR-2021, the patient experienced headache, extreme fatigue, joint pain. The patient received an unknown treatment. The outcome of the events was recovered.  No follow-up attempts are possible; Information about lot/batch number cannot be obtained.
Sore arm; Tired; Headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), FATIGUE (Tired) and HEADACHE (Headache) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore arm), FATIGUE (Tired) and HEADACHE (Headache). At the time of the report, PAIN IN EXTREMITY (Sore arm), FATIGUE (Tired) and HEADACHE (Headache) outcome was unknown.            Concomitant medications are not provided. Treatment information does not provided. The action taken with the drug was Not applicable.
Reports testing positive for COVID 4/7/21. Completed COVID vaccine series 2/15/21.
Arm burning, pain, and redness around injection site approximately 3 hours after injection.  Also patient had a fever.
nausea; fatigue; headache; fever; This spontaneous case was reported by a non-health professional and describes the occurrence of NAUSEA (nausea), FATIGUE (fatigue), HEADACHE (headache) and PYREXIA (fever) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) unknown. On an unknown date, the patient experienced NAUSEA (nausea), FATIGUE (fatigue), HEADACHE (headache) and PYREXIA (fever). At the time of the report, NAUSEA (nausea), FATIGUE (fatigue), HEADACHE (headache) and PYREXIA (fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       concomitants were not provided.
Observed pt passed out on bench in doctor's office after having Hep A and HPV vaccines. Pt was rigid, with feet stretched out, eyes rolled back, pt was disoriented. Pt was passed out for about 60 sec. Pt was evaluated by doctor.
Per mom L deltoid area was very indurated and painful last night 02/22/07. Pt was vaccinated 2-21-07. Today 2-23-07 L deltoid area is red and warm with no induration about 6x5.5 cm with minimal pain.
after the vaccine,  i got alot of symptions,  loose stool,  aniexty, depression, and gastric,  start after the vaccine,
Very hot-temp not taken; high pitched scream 9-10 hrs, leg very swollen-hot;
Pt reports itching at injection site, felt hot burning sensation, tightness, swelling in arm , shoulder and neck pain. Decreased ROM.
1 day p/vax pt devel swelling from elbow to shoulder, warm to touch, swelling to hand; some dyspnea;rx Clindamycin, Atrobent, inhaler, hydroxyz
Arm that shot was administered is in an extreme amount of pain. I was expecting some soreness but not to this extent.
anaphylaxis; mid-back pain; coughing; wheezing; SOB; severe pain in chest; flushing and itching immediately; itching; This is a spontaneous report from a contactable consumer (patient). A non-pregnant 49-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration, administered in arm left on 27Apr2021 15:15 (Batch/Lot Number: ER8733) (at age 49-years-old) as dose 1, single for covid-19 immunisation. Medical history included kidney stones, chronic migraines, sinusitis, numerous food/environmental allergies and penicillin allergies. Concomitant medications included ZYRTEC, TOPAMAX, spironolactone, VITAMIN D, and BENADRYL, all taken for an unspecified indication, start and stop date were not reported. The patient previously took cephalasporins, oral Diflucan, clindamycin, PEG, Polysorbate, Propylene glycol, sulfa, Levaquin and experienced allergies. The patient had known allergies to polysorbate, polyethylene glycol, and propylene glycol, but patient was approved for vaccine with pre-meds of Benadryl to take 45 min prior to Pfizer vaccine in hospital setting. Nurse observed her for 1 hour after. ER was next to room. Patient experienced flushing, itching immediately on 27Apr2021, and was given oral Benadryl 5-10 min after shot. She went home, slept for 3-4 hours and woke up with mid-back pain and starting coughing, wheezing, and SOB on 27Apr2021 20:45. She was unable to catch her breath. Patient recognized symptoms of anaphylaxis. She was advised to return to ER if she had any symptoms and she returned to ER immediately. She had to explain to ER staff/docs that she had covid vaccine earlier and this was a reaction, but staff and doctor stated it would have happened immediately. Patient had to re-explain that she was pre-medicated with Benadryl prior to vaccine due to allergies and after meds wore off, she experienced anaphylaxis on 27Apr2021 20:45. Patient had a very hard time with non-stop coughing for over an hour, shortness of breath, wheezing, and severe pain in chest and back. The events resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Treatment included additional medications/ steroid given in ER. Outcome of the events was recovered with sequel. Patient was diagnosed with COVID-10 prior to vaccination and had been tested post-vaccination on 24Mar2021: negative.
Pt recvd 3 doses (dates not recorded) of Engerix B. Titers were checked 6 mos p/ last dose. Titer result was 8.1 indicating a low positive response.
From an initial report received on 01/04/2001, it was reported a 19 year old female received Menomune vaccination on 10/18/2000. Reportedly "student initially complained of feeling faint
Information has been received from a registered nurse referring to an unspecified patient of unknown age. On 30-MAR-2015 the patient received an expired dose of M-M-R II (lot# J002867, expiration date:08-MAR-2015, strength, route and dose were unknown). No adverse effects reported. Additional information has been requested.
Patient reported to me on 9/13/2021 that she had a "seizure" that night, witnessed by her brother.  She didn't seek medical attention. Prior to the event she felt hot and then she found herself on the ground.  She has not seen a physician since but is refusing the second dose
Site: Pain at Injection Site-Medium, Systemic: Confusion-Medium, Systemic: Dizziness / Lightheadness-Medium, Systemic: Fainting / Unresponsive-Medium, Systemic: Flushed / Sweating-Medium, Systemic: Nausea-Medium, Systemic: Tingling (specify: facial area, extemities)-Medium, Additional Details: Tingling was only located in fingers and hands. Patients Blood Pressure after event was recorded at 106/58. Patient states he naturally runs lower blood pressure and heart rate. Also mentioned that he has a fear of needles.. Patient is now responsive and feeling better.
This case was reported by a nurse and described the occurrence of headache in a 84-year-old female patient who received SHINGRIX (batch number 9779K, expiry date 11th October 2020). On an unknown date, the patient received SHINGRIX (intramuscular) .5 ml. On 1st May 2018, less than a year after receiving SHINGRIX, the patient experienced headache, shoulder pain and neck pain. In May 2018, the outcome of the headache, shoulder pain and neck pain were recovered/resolved. It was unknown if the reporter considered the headache, shoulder pain and neck pain to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported.
low blood pressure; This case was reported by a consumer via other manufacturer and described the occurrence of low blood pressure in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced low blood pressure. On an unknown date, the outcome of the low blood pressure was unknown.   It was unknown if the reporter considered the low blood pressure to be related to Shingrix.  Additional details provided were as follows: The case was reported by patient himself/herself. Age at vaccination was not reported. The patient received a dose of Shingrix and experienced low blood pressure. No additional adverse event/product complaint case was reported at the time of call. Follow-up would not be possible as no contact details available.
dose given past the 12 hour post puncture time; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (dose given past the 12 hour post puncture time) in an 18-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Sep-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (dose given past the 12 hour post puncture time). On 15-Sep-2021, EXPIRED PRODUCT ADMINISTERED (dose given past the 12 hour post puncture time) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant medications were reported. No Treatment information was reported.
At approximately 11:45 a.m. on the date of the injection my hands became freezing cold. This lasted for approximately 16 hours. My skin has since been very sensitive to touch, this includes skin on my face, arms, hands, and chest. I am very sensitive to temperature changes, especially cold. My nervous systems feels very sensitive, especially my hands. Touching cold items (refrigerator, outside, etc.) makes me shiver. I have also been experiencing a covid fog. I do not feel like myself and am not experiencing joy. I cry daily for no reason.
Upper extremity edema:  Injection site induration; skin erythema-- Information has been received from a health care department concerning a female patient who was vaccinated with measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation).  Subsequently the patient experienced left arm swelling, erythema and induration in the injected arm.  It was noted by the reporter that the patient's experiences were attributed to the measles (+) mumps (+) rubella vaccine.  Follow up information from the health care facility indicated that there was no new information.